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Gastric Electrical Stimulation: A Report of Two Cases
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Abstract
Gastroparesis refractory to prokinetic agents poses a major challenge to the physician and patient, alike. In the past
5 years, electrical methods to treat gastroparesis have emerged from animal and human experiments to a potentially
valuable tool in clinical gastroenterology. One of these methods, known as gastric electrical stimulation (GES), is
being increasingly used in specialized centres worldwide, but had never been tried in Ireland. We describe here our
experience with the first two implantations of gastric neurostimulators performed in Ireland and the outcome with
these 2 patients. Our results at 6 months show reduction in symptoms and improvement in quality of life, which is
encouraging and should prompt further evaluation of GES for patients with gastroparesis refractory to medical therapy.
Introduction
Gastroparesis can be defined as a disturbance in gastric motility, resulting in delayed emptying of a solid, liquid or
mixed meal. The predominant symptoms are nausea, vomiting, abdominal pain, early satiety, bloating and anorexia.
Diabetes Mellitus is the commonest cause of gastroparesis, although other known causes include gastric surgery, viral
infections, systemic sclerosis, Parkinsonâs disease and drugs such as anticholinergics and dopaminergic agents.
Though rare, chronic diabetic gastroparesis poses a major challenge to both diabetologist and gastroenterologist,
especially when symptoms are persistent and severe, do not respond to prokinetic agents such as domperidone,
metoclopromide, erythromycin (a motilin agonist) and cisapride and impact on the patientâs nutrition and diabetic
control. Restrictions on the prescription of cisapride due to its potential cardiotoxicity have compounded matters
further.
Gastric Electrical Stimulation(GES), though still regarded by many as experimental, has emerged in recent years as a
therapeutic tool in cases of prokinetic-refractory gastroparesis. Three different types have emerged-gastric
electrical pacing, neural electrical gastric stimulation, and high-frequency gastric electrical stimulation. The first
two types have been mainly experimental, with the latter type, high-frequency GES, showing more promise and described
in this report. Numerous clinical trials1,2,3 have demonstrated favourable results of high-frequency GES in chronic,
refractory gastroparesis, but we have had no experience of this novel therapy in Ireland up to now. We have overseen
the first two implantations of a gastric electrical stimulator in Ireland, and describe here the procedure, its
rationale, our experience and results.
Basis of Gastric Electrical Stimulation (GES)
Gastric myoelectrical activity originates from an area along the greater curvature of the stomach, the âpacemakerâ
area, which consists of specialized cells known as the interstitial cells of Cajal (ICC). The motility-generating
structures of the gastric wall, which comprises the ICC and the gastric musculature, are integrated to produce a
peristaltic wave, initiated by a synchronized electrical signal, which traverses the entire stomach in an orderly
aborad fashion. Thus, an external electrical stimulus delivered to the gastric wall may influence the electrical
activity of any one or all of these structures, which are commonly dysfunctional in gastroparesis. The theoretical
consequence is therefore a modification of contractility, and, ultimately, function.
One approach that has emerged uses a high frequency stimulus, and is the one used in our patients. However, with
high-frequency GES, gastric motility and gastric emptying are not restored, but strangely enough, there are marked
effects on symptoms, especially nausea and vomiting.3 This is thought to be due to a modulation of afferent neural
activity, thereby, influencing symptom perception and also possibly influencing the central control of nausea and
vomiting.4
Methods
Figure 1
Two patients were identified as suitable for GES. Patient 1 was a 23 year old male with type 1 diabetes mellitus for
16 years.
He had repeated admissions since 2000 with intractable vomiting secondary to gastroparesis unresponsive to
prokinetics. Patient 2 was a 60 year old female, referred from another University Teaching Hospital, where she was
repeatedly admitted with severe gastroparesis over the past 2 years. Her isotope gastric emptying test showed delayed
gastric emptying.
The GES system consisted of 2 electrodes implanted to the gastric wall and a neurostimulator (Enterra, Medtronic)
inserted subcutaneously (see Figure 1). The procedure was performed by a cardiothoracic surgeon.
Table 1: Number of days spent in hospital in 2003 and 2004. spent in hospital by Patient 1 in 2003 and 2004
Neurostimulator inserted February
Pre- stimulator Post-stimulator
Feb 8 Mar 0
Mar 9 Ap 18
Apr 18 May 12
May 0 Jun 0
Jun 0 Jul 0
Jul 0 Aug 15
Aug 14 Sep 14
Sep 10 Oct 12
Oct 15 Nov 0
Nov 30 Dec 0
Dec 12 Jan 9
Jan 0 Feb 0
Feb 0 Mar 16
Total number of days 116 87
After 6 months, both patients reported improvement in symptoms as assessed by a patient diary. Daily episodes of
nausea and vomiting were markedly reduced. Table 1 shows hospital admissions for Patient 1. More limited data
available from Patient 2, who was being managed in another tertiary centre, is shown as 6 months pre and post gastric
stimulator insertion in Table 2.
Table 2: Number of days spent in hospital by Patient 2 Neurostimulator inserted February
Pre- stimulator Post-stimulator
Sep 21 Mar 12
Oct 31 Apr 0
Nov 30 May 0
Dec 16 Jun 0
Jan 0 Jul 0
Feb 11 Aug 15
Total no of days 109 27
The hospital readmission rate however did not seem to be markedly affected for patient 1, although patient 2 had no
hospitalization for 4 months (see Figure 2), suggesting that the rate of acute attacks may not be influenced in a
major way. Further long-term follow-up should elucidate this.
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Figure 2: Days spent in hospital from
September 2003 to August 2004
Conclusions
Our experience with GES, though limited and preliminary, has, so far, been encouraging. At the time of stimulator
insertion here, only about 15 had been implanted in the UK. Studies have shown that at least 75% of diabetic
gastroparesis patients can expect a significant improvement in weekly vomiting frequency and quality of life,3 which is
so markedly impaired in this category of patients.5 Global experience with GES is still at an early stage, and future
refinements in the technology should pave the way for more effective systems.
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